Bictegravir Use During Pregnancy: A Multicenter Retrospective Analysis Evaluating HIV Viral Suppression and Perinatal Outcomes.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 38666408.
- Also identified by DOI 10.1093/cid/ciae218 and PMC identifier 12098006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study describes the largest cohort to date (n = 147) of pregnant patients with human immunodeficiency virus (HIV) on bictegravir (BIC). BIC in pregnancy was associated with high levels of viral suppression and perinatal outcomes similar to those in the published literature. These findings support consideration for the use of BIC in managing HIV during pregnancy.
Medical subject headings
- HIV Infections
- Pregnancy Complications, Infectious
- Heterocyclic Compounds, 3-Ring
- Viral Load